Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by NEEDS, C. J.
Right arrow Articles by BROOKS, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NEEDS, C. J.
Right arrow Articles by BROOKS, P. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1985 British Society for Rheumatology

review-article

ANTIRHEUMATIC MEDICATION DURING LACTATION

C. J. NEEDS and P. M. BROOKS1

Department of Rheumatology, Royal North Shore Hospital St. Leonards, NSW, Australia

Correspondence to: 1Address correspondence to Professor P. M. Brooks.

All nonsteroidal anti-inflammatory drugs (NSAIDs) and antirheumatic drugs are likely to be distributed into human milk to some extent; whether they are detected is a function of the assay sensitivity. For minimal infant exposure, the ideal drug for lactating women is one which (a) has a short half-life, (b) is found in minimal quantities in human milk and (c) has inactive metabolites which also are present only in small amounts. In order to reduce the quantity of drug presented to the child, the drug should be taken by the mother at the time of breast-feeding with the next feed occurring after a time period equivalent to one half-life of the drug.

Using the above-mentioned criteria, the choice of NSAIDs would be between a short half-life propionic acid derivative, with little biotransformation, such as ibuprofen or flurbiprofen. Diclofenac is also suitable. Gold salts and corticosteroids would seem safe to prescribe. However, the infant should be closely monitored if antimalarials are being used by lactating women.

KEY WORDS: Anti-rheumatic drugs, Lactation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
N. M. Janssen and M. S. Genta
The Effects of Immunosuppressive and Anti-inflammatory Medications on Fertility, Pregnancy, and Lactation
Arch Intern Med, March 13, 2000; 160(5): 610 - 619.
[Abstract] [Full Text] [PDF]

Home page
 J Hum LactHome page
A. M. Ebert
Use of Nonnarcotic Analgesics during Breastfeeding
J Hum Lact, March 1, 1997; 13(1): 61 - 64.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.